Michaud, Lausanne (Mdecine de ladolescence)
A clinician can guide you on protein intake and resistance training to ensure the weight you lose is primarily fat
The SELECT trial showed that semaglutide 2.4 mg (Wegovy) reduces cardiovascular risk in adults with established cardiovascular disease and either overweight or obesity, leading to an FDA-approved indication for reducing cardiovascular risk in this population
Xylitol*, Aqua*, Calcium Carbonate*, Cocos Nucifera Oil*, Hydrated Silica*, Hydroxyapatite*, Silica*, Xanthan Gum*, Aroma*, Sodium Methyl Cocoyl Taurate*, Montmorillonite *, Calcium Pantothenate, Camellia Oleifera Seed Oil*, Glycerin*, Mentha Piperita Oil*, Menthol*, Phenoxyethanol, Ethylhexylglycerin, Illite*, Kaolin*, Citrus Limon Peel Oil*, Eugenia Caryophyllus Flower Oil*, Sodium Saccharin, Eugenol*, Limonene*, Beta-caryophyllene*, Eugenyl Acetate*, Pinene*